Table 1 Identification of end-point myocardial infarctions in the PURSUIT trial
From: Systematic adjudication of myocardial infarction end-points in an international clinical trial
Region | CEC MI only | Site MI only | Both CEC + site MI | Neither CEC nor site MI |
|---|---|---|---|---|
Eastern Europe (n = 1762) | 182 (10.3%) | 24 (1.4%) | 129 (7.3%) | 1427 (81.0%) |
Latin America (n = 585) | 44 (7.5%) | 8 (1.4%) | 24 (4.1%) | 509 (87.0%) |
North America (n = 4358) | 299 (6.9%) | 57 (1.3%) | 205 (4.7%) | 3797 (87.1%) |
Western Europe (n = 4243) | 291 (6.9%) | 78 (1.8%) | 241 (5.7%) | 3633 (85.6%) |
Overall (n = 10,948) | 816 (7.5%) | 167 (1.5%) | 599 (5.5%) | 9366 (85.6%) |